- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Cardiology
The Endocrinology Network® Cardiology clinical resource center is a hub of news related to cardiovascular health that is relevant to clinicians interested in endocrinology. This page will host relevant content about cardiology and cardiovascular disease including guideline updates, new studies and breakthroughs, and clinical perspectives for practicing clinicians.
Endocrine Month in Review: November 2021
November 27, 2021
November's endocrine month in review features stories on the Build Back Better Act, a recent review from the IOF, data from Kidney Week 2021, and more.
Bariatric Surgery Dramatically Lowers Liver, Cardiovascular Risk in Patients with NASH
November 23, 2021
Undergoing bariatric surgery was associated with reductions in risk of adverse liver outcomes and MACE versus nonsurgical management among patients with obesity and biopsy-proven nonalcoholic steatohepatitis in the SPLENDOR study.
Patients with Diabetes Less Likely to Recognize, Report AFib Symptoms
November 20, 2021
Data from the SWISS-AF study is providing clinicians with insight into the likelihood of patients to perceive symptoms of atrial fibrillation based on whether or not they had diabetes.
International Osteoporosis Foundation Issues Review of Links Between Bone Loss and Vascular Calcification
November 18, 2021
The latest review from the International Osteoporosis Foundation is a 14-page document with more than 100 references outlining current data related to the pathophysiological links between vascular calcification and bone loss.
ASCEND: Aspirin Use Does Not Influence Dementia Risk in Patients with Diabetes
November 16, 2021
Data from the ASCEND trial provide clinicians with insight into the risk of dementia based on long-term use of low-dose aspirin among patients with diabetes and no history of cardiovascular disease.
Optimal Prescription of Dapagliflozin in Hospitalized Patients Could Reduce Death, Readmission at 1 Year
November 15, 2021
Data from the TRANSLATE-HF program suggests optimal prescription of SGLT2 inhibitors among hospitalized patients could have a significant impact on the risk of death and hospital readmission in the next year.
The PA Experience at ACLM 2021: Lettuce Discuss Benefits of Lifestyle Medicine
November 13, 2021
Laura Ross, PA-C, details her experience at the American College of Lifestyle Medicine 2021 meeting and the role of lifestyle modification in preventive medicine.
CLICK Trial: Chlorthalidone Reduces BP in Chronic Kidney Disease and Uncontrolled Hypertension
November 10, 2021
Data from the CLICK trial presented at Kidney Week 2021 demonstrates chlorthalidone reduced systolic blood pressure by 11 mmHg over a 12-week treatment period among a patient population with stage 4 CKD and uncontrolled hypertension.
Risk Model Suggests SGLT2 Inhibitors Could Reduce CV, Renal Risk in Type 1 Diabetes
November 08, 2021
Using the Steno Type 1 Risk Engine, a team from Denmark conducted a study suggesting SGLT2 inhibition could lower risk of cardiovascular disease and end-stage kidney disease in patients with type 1 diabetes.
Finerenone Could Reduce Progression to Dialysis in Type 2 Diabetes and CKD
November 07, 2021
An analysis of secondary end points from FIGARO-DKD presented at Kidney Week 2021 provides further insight into the effects of finerenone on kidney outcomes, including a 36% reduction in need for dialysis.